EP0463407 - Use of dihydropyridins in cardiotonic pharmaceutical compositions [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.12.2002 Database last updated on 09.05.2025 | Most recent event Tooltip | 07.12.2007 | Lapse of the patent in a contracting state New state(s): IT | published on 09.01.2008 [2008/02] | Applicant(s) | For all designated states Mitsubishi Pharma Corporation 6-9, Hiranomachi 2-chome, Chuo-ku Osaka-shi Osaka 541-0046 / JP | [N/P] |
Former [2002/05] | For all designated states Mitsubishi Pharma Corporation 6-9, Hiranomachi 2-chome, Chuo-ku Osaka-shi, Osaka 541-0046 / JP | ||
Former [2001/10] | For all designated states Welfide Corporation 6-9, Hirano-machi 2-chome, Chuo-ku Osaka-shi, Osaka-fu / JP | ||
Former [1999/41] | For all designated states YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. 6-9, Hiranomachi 2-chome Chuo-ku Osaka-shi Osaka / JP | ||
Former [1992/01] | For all designated states THE GREEN CROSS CORPORATION 3-3, Imabashi 1-chome Chuo-ku Osaka-shi Osaka 541 / JP | Inventor(s) | 01 /
Uchida, Takeshi, c/o The Green Cross Corporation Central Research Lab., 2-1180-1, Shodaiohtani Hirakata-shi, Osaka 573 / JP | 02 /
Ohtaki, Yutaka, c/o The Green Cross Corporation Central Research Lab., 2-1180-1, Shodaiohtani Hirakata-shi, Osaka 573 / JP | 03 /
Kido, Hideaki, c/o The Green Cross Corporation Central Research Lab., 2-1180-1, Shodaiohtani Hirakata-shi, Osaka 573 / JP | 04 /
Watanabe, Masahiro, c/o The Green Cross Corp. Central Research Lab., 2-1180-1, Shodaiohtani Hirakata-shi, Osaka 573 / JP | [1992/01] | Representative(s) | dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | [N/P] |
Former [1992/01] | von Kreisler, Alek, Dipl.-Chem., et al Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41 D-50462 Köln / DE | Application number, filing date | 91109081.9 | 04.06.1991 | [1992/01] | Priority number, date | JP19900166093 | 25.06.1990 Original published format: JP 16609390 | [1992/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0463407 | Date: | 02.01.1992 | Language: | EN | [1992/01] | Type: | A3 Search report | No.: | EP0463407 | Date: | 23.12.1992 | Language: | EN | [1992/52] | Type: | B1 Patent specification | No.: | EP0463407 | Date: | 13.02.2002 | Language: | EN | [2002/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 05.11.1992 | Classification | IPC: | A61K31/444, A61K31/496, A61K31/4427, A61K31/4422, A61P9/04 | [2001/08] | CPC: |
A61K31/44 (EP,KR);
A61P9/04 (EP)
|
Former IPC [2001/06] | A61K31/444, A61K31/496, A61K31/4427, A61K31/4422 | ||
Former IPC [1992/52] | A61K31/44, A61K31/495 | ||
Former IPC [1992/01] | A61K31/44 | Designated contracting states | BE, CH, DE, DK, ES, FR, GB, IT, LI, NL, SE [1992/01] | Title | German: | Verwendung von Dihydropyridinen in kardiotonischen pharmazeutischen Zusammensetzungen | [1992/01] | English: | Use of dihydropyridins in cardiotonic pharmaceutical compositions | [1992/01] | French: | Utilisation des dérivés de la dihydropyridine dans des compositions pharmaceutiques cardiotoniques | [1992/01] | Examination procedure | 26.02.1993 | Examination requested [1993/17] | 31.01.1995 | Despatch of a communication from the examining division (Time limit: M06) | 29.07.1995 | Reply to a communication from the examining division | 08.02.1996 | Despatch of a communication from the examining division (Time limit: M04) | 04.06.1996 | Reply to a communication from the examining division | 11.02.1998 | Despatch of a communication from the examining division (Time limit: M06) | 13.08.1998 | Reply to a communication from the examining division | 17.01.2001 | Despatch of communication of intention to grant (Approval: No) | 10.05.2001 | Despatch of communication of intention to grant (Approval: later approval) | 29.05.2001 | Despatch of a communication from the examining division (Time limit: M04) | 06.06.2001 | Reply to a communication from the examining division | 27.07.2001 | Communication of intention to grant the patent | 02.11.2001 | Fee for grant paid | 02.11.2001 | Fee for publishing/printing paid | Opposition(s) | 14.11.2002 | No opposition filed within time limit [2003/06] | Fees paid | Renewal fee | 26.06.1993 | Renewal fee patent year 03 | 28.06.1994 | Renewal fee patent year 04 | 26.06.1995 | Renewal fee patent year 05 | 26.06.1996 | Renewal fee patent year 06 | 27.06.1997 | Renewal fee patent year 07 | 27.06.1998 | Renewal fee patent year 08 | 29.06.1999 | Renewal fee patent year 09 | 29.06.2000 | Renewal fee patent year 10 | 23.06.2001 | Renewal fee patent year 11 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | BE | 13.02.2002 | CH | 13.02.2002 | IT | 13.02.2002 | LI | 13.02.2002 | NL | 13.02.2002 | DK | 13.05.2002 | SE | 13.05.2002 | ES | 29.08.2002 | [2008/02] |
Former [2004/04] | BE | 13.02.2002 | |
CH | 13.02.2002 | ||
LI | 13.02.2002 | ||
NL | 13.02.2002 | ||
DK | 13.05.2002 | ||
SE | 13.05.2002 | ||
ES | 29.08.2002 | ||
Former [2003/45] | BE | 13.02.2002 | |
CH | 13.02.2002 | ||
LI | 13.02.2002 | ||
NL | 13.02.2002 | ||
DK | 13.05.2002 | ||
SE | 13.05.2002 | ||
Former [2003/06] | BE | 13.02.2002 | |
CH | 13.02.2002 | ||
LI | 13.02.2002 | ||
NL | 13.02.2002 | ||
SE | 13.05.2002 | ||
Former [2003/01] | CH | 13.02.2002 | |
LI | 13.02.2002 | ||
SE | 13.05.2002 | ||
Former [2002/37] | SE | 13.05.2002 | Documents cited: | Search | [X]EP0257616 (GREEN CROSS CORP [JP]); | [Y]US4735956 (BALDWIN JOHN J [US], et al); | [X]EP0342577 (GREEN CROSS CORP [JP]); | [XP]EP0379737 (GREEN CROSS CORP [JP]) | [X] - FOLIA PHARMACOLOGICA JAPONICA, vol. 95, no. 4, April 1990, pages 177-184; H. KIDO et al.: "Angiographic studies on the effects of a novel calcium antagonist AE0047 on cerebral arteries in dogs, with special reference to the preventive effects of AE0047 on cerebral vasoconstriction induced by endothelin" |